Skip to content

Low Anterior Resection Syndrome and Rectal Irrigation Study

Low Anterior Resection Syndrome and Rectal Irrigation Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04246775
Acronym
LARRIS
Enrollment
22
Registered
2020-01-29
Start date
2015-04-30
Completion date
2016-07-31
Last updated
2020-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Resection Syndrome

Brief summary

Prospective study assessing treatment acceptability and the impact of rectal irrigation on patients with low anterior resection syndrome (LARS) in terms of quality of life and bowel function.

Detailed description

Aims: To assess if rectal irrigation improves patient symptoms and quality of life in patients with LARS and to see if the treatment is acceptable to patients. Methods: This is a mixed methods evaluation study on functional outcomes in patients who have undergone anterior resection for rectal neoplasia and who have had bowel continuity restored between Jan 2009 and Jan 2014. Those patients deemed to have LARS who consent to participation in the study will be offered rectal irrigation.

Interventions

DEVICEPeristeen

rectal irrigation

Sponsors

South East Wales Trials Unit (SEWTU)
CollaboratorUNKNOWN
Tenovus
CollaboratorUNKNOWN
Cardiff and Vale University Health Board
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients who have undergone anterior resection for rectal neoplasia, patients who have had restored bowel continuity * LARS score of \>20 (defined LARS syndrome) * patients \> 18 years of age.

Exclusion criteria

* previous use of rectal irrigation * patients who are unable to give informed consent * patients who are not physically capable of performing the treatment in their home

Design outcomes

Primary

MeasureTime frameDescription
SF12pre intervention and 6 months postquality of life

Secondary

MeasureTime frameDescription
EORTCpre intervention and 6 months postquality of life
Low anterior resection scorepre intervention and 6 months postbowel function
St Marks Faecal incontinence scorepre intervention and 6 months postbowel function
treatment acceptability questionnairepost training for treatment and 6 months post treatment

Other

MeasureTime frame
qualitative interviewsafter 6 months treatment or drop out from treatment group

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026